In the demanding world of pharmaceutical manufacturing, the reliability and quality of raw materials are paramount. For companies involved in the production of cardiovascular drugs, securing a consistent supply of key intermediates is non-negotiable. One such critical compound is 11-Alpha-Hydroxycanrenone Methyl Ester, identified by its CAS number 192704-56-6. This high-purity chemical plays an indispensable role as a precursor in the synthesis of Eplerenone, a widely used medication for treating hypertension and heart failure.

Eplerenone, a selective aldosterone receptor antagonist, has become a cornerstone in managing cardiovascular conditions. Its efficacy relies heavily on the purity and structural integrity of its precursors. 11-Alpha-Hydroxycanrenone Methyl Ester, often referred to by synonyms such as 11-alpha-hydroxymexrenone, provides the essential chemical scaffolding required for the successful and efficient synthesis of Eplerenone. The compound's specific stereochemistry and functional groups are precisely what is needed to build the complex Eplerenone molecule.

For procurement managers and R&D scientists in the pharmaceutical sector, understanding the supply landscape for such intermediates is crucial. China has emerged as a global hub for pharmaceutical chemical manufacturing, offering both high-quality products and competitive pricing. When looking to buy 11-Alpha-Hydroxycanrenone Methyl Ester, partnering with a reputable manufacturer in China can significantly impact project timelines and budget adherence. These manufacturers are equipped with advanced synthesis technologies and stringent quality control systems to ensure that the product meets international standards.

The benefits of sourcing this pharmaceutical intermediate from a dedicated China manufacturer extend beyond just cost. These suppliers often provide comprehensive documentation, including Certificates of Analysis (CoA), detailing the product's purity, chemical properties, and compliance with industry regulations. For instance, a white to off-white solid form is typically expected, and detailed specifications on assay and impurity profiles are critical for pharmaceutical applications. This transparency is vital for regulatory submissions and ensures that the final drug product is safe and effective for patients.

When considering the purchase of 11-Alpha-Hydroxycanrenone Methyl Ester, it is advisable to inquire about bulk pricing and available lead times. Many suppliers offer tiered pricing structures, providing significant cost savings for larger orders, which is advantageous for manufacturers scaling up production. Furthermore, understanding the supplier's production capacity and their ability to consistently meet demand is a key factor in building a robust supply chain. Choosing a manufacturer that prioritizes customer service and technical support can also facilitate a smoother procurement process, ensuring that any queries regarding product specifications or logistics are promptly addressed.

In conclusion, for pharmaceutical companies dedicated to advancing cardiovascular therapies, securing a dependable source of 11-Alpha-Hydroxycanrenone Methyl Ester is essential. By partnering with experienced China manufacturers, businesses can gain access to high-purity pharmaceutical intermediates at competitive prices, backed by quality assurance and reliable delivery. This strategic sourcing approach not only supports efficient drug development but also contributes to making critical medications more accessible worldwide.